Skip to main content

Table 3 Multivariate analysis of prognostic factors in 341 node negative patients aged less than 40 years

From: Impact of established prognostic factors and molecular subtype in very young breast cancer patients: pooled analysis of four EORTC randomized controlled trials

 

Overall survival

Distant disease-free survival

 

HR

95% CI

P

HR

95% CI

P

pT2 + pT3

1.75

0.99 to 3.10

0.06

1.33

0.83 to 2.15

0.24

Molecular subtype

  

0.02

  

0.08

   Basal

1

  

1

  

   Luminal A

0.22

0.08 to 0.60

 

0.46

0.25 to 0.85

 

   HER2

0.25

0.03 to 1.85

 

0.53

0.16 to 1.73

 

   Luminal B

0.87

0.48 to 1.59

 

0.82

0.49 to 1.38

 

Adjuvant chemotherapy

0.96

0.38 to 2.45

0.94

  Â